Global Daratumumab Market Growth 2022-2028
- LP 4768520
- 79 Pages
- January 2022
- Pharmaceuticals
The United States Daratumumab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Daratumumab market, reaching US$ million by the year 2028. As for the Europe Daratumumab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Daratumumab players cover Johnson＆Johnson, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Daratumumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
100mg Injection
400mg Injection
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Multiple Myeloma
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Mantle Cell Lymphoma
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Johnson＆Johnson
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Daratumumab Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Daratumumab by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Daratumumab by Country/Region, 2017, 2022 & 2028
2.2 Daratumumab Segment by Type
2.2.1 100mg Injection
2.2.2 400mg Injection
2.3 Daratumumab Sales by Type
2.3.1 Global Daratumumab Sales Market Share by Type (2017-2022)
2.3.2 Global Daratumumab Revenue and Market Share by Type (2017-2022)
2.3.3 Global Daratumumab Sale Price by Type (2017-2022)
2.4 Daratumumab Segment by Application
2.4.1 Multiple Myeloma
2.4.2 Diffuse Large B Cell Lymphoma
2.4.3 Follicular Lymphoma
2.4.4 Mantle Cell Lymphoma
2.4.5 Other
2.5 Daratumumab Sales by Application
2.5.1 Global Daratumumab Sale Market Share by Application (2017-2022)
2.5.2 Global Daratumumab Revenue and Market Share by Application (2017-2022)
2.5.3 Global Daratumumab Sale Price by Application (2017-2022)
3 Global Daratumumab by Company
3.1 Global Daratumumab Breakdown Data by Company
3.1.1 Global Daratumumab Annual Sales by Company (2020-2022)
3.1.2 Global Daratumumab Sales Market Share by Company (2020-2022)
3.2 Global Daratumumab Annual Revenue by Company (2020-2022)
3.2.1 Global Daratumumab Revenue by Company (2020-2022)
3.2.2 Global Daratumumab Revenue Market Share by Company (2020-2022)
3.3 Global Daratumumab Sale Price by Company
3.4 Key Manufacturers Daratumumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Daratumumab Product Location Distribution
3.4.2 Players Daratumumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Daratumumab by Geographic Region
4.1 World Historic Daratumumab Market Size by Geographic Region (2017-2022)
4.1.1 Global Daratumumab Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Daratumumab Annual Revenue by Geographic Region
4.2 World Historic Daratumumab Market Size by Country/Region (2017-2022)
4.2.1 Global Daratumumab Annual Sales by Country/Region (2017-2022)
4.2.2 Global Daratumumab Annual Revenue by Country/Region
4.3 Americas Daratumumab Sales Growth
4.4 APAC Daratumumab Sales Growth
4.5 Europe Daratumumab Sales Growth
4.6 Middle East & Africa Daratumumab Sales Growth
5 Americas
5.1 Americas Daratumumab Sales by Country
5.1.1 Americas Daratumumab Sales by Country (2017-2022)
5.1.2 Americas Daratumumab Revenue by Country (2017-2022)
5.2 Americas Daratumumab Sales by Type
5.3 Americas Daratumumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Daratumumab Sales by Region
6.1.1 APAC Daratumumab Sales by Region (2017-2022)
6.1.2 APAC Daratumumab Revenue by Region (2017-2022)
6.2 APAC Daratumumab Sales by Type
6.3 APAC Daratumumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Daratumumab by Country
7.1.1 Europe Daratumumab Sales by Country (2017-2022)
7.1.2 Europe Daratumumab Revenue by Country (2017-2022)
7.2 Europe Daratumumab Sales by Type
7.3 Europe Daratumumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Daratumumab by Country
8.1.1 Middle East & Africa Daratumumab Sales by Country (2017-2022)
8.1.2 Middle East & Africa Daratumumab Revenue by Country (2017-2022)
8.2 Middle East & Africa Daratumumab Sales by Type
8.3 Middle East & Africa Daratumumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Daratumumab
10.3 Manufacturing Process Analysis of Daratumumab
10.4 Industry Chain Structure of Daratumumab
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Daratumumab Distributors
11.3 Daratumumab Customer
12 World Forecast Review for Daratumumab by Geographic Region
12.1 Global Daratumumab Market Size Forecast by Region
12.1.1 Global Daratumumab Forecast by Region (2023-2028)
12.1.2 Global Daratumumab Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Daratumumab Forecast by Type
12.7 Global Daratumumab Forecast by Application
13 Key Players Analysis
13.1 Johnson＆Johnson
13.1.1 Johnson＆Johnson Company Information
13.1.2 Johnson＆Johnson Daratumumab Product Offered
13.1.3 Johnson＆Johnson Daratumumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Johnson＆Johnson Main Business Overview
13.1.5 Johnson＆Johnson Latest Developments
14 Research Findings and Conclusion
Table 1. Daratumumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Daratumumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 100mg Injection
Table 4. Major Players of 400mg Injection
Table 5. Global Daratumumab Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Daratumumab Sales Market Share by Type (2017-2022)
Table 7. Global Daratumumab Revenue by Type (2017-2022) & ($ million)
Table 8. Global Daratumumab Revenue Market Share by Type (2017-2022)
Table 9. Global Daratumumab Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Daratumumab Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Daratumumab Sales Market Share by Application (2017-2022)
Table 12. Global Daratumumab Revenue by Application (2017-2022)
Table 13. Global Daratumumab Revenue Market Share by Application (2017-2022)
Table 14. Global Daratumumab Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Daratumumab Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Daratumumab Sales Market Share by Company (2020-2022)
Table 17. Global Daratumumab Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Daratumumab Revenue Market Share by Company (2020-2022)
Table 19. Global Daratumumab Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Daratumumab Producing Area Distribution and Sales Area
Table 21. Players Daratumumab Products Offered
Table 22. Daratumumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Daratumumab Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Daratumumab Sales Market Share Geographic Region (2017-2022)
Table 27. Global Daratumumab Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Daratumumab Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Daratumumab Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Daratumumab Sales Market Share by Country/Region (2017-2022)
Table 31. Global Daratumumab Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Daratumumab Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Daratumumab Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Daratumumab Sales Market Share by Country (2017-2022)
Table 35. Americas Daratumumab Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Daratumumab Revenue Market Share by Country (2017-2022)
Table 37. Americas Daratumumab Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Daratumumab Sales Market Share by Type (2017-2022)
Table 39. Americas Daratumumab Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Daratumumab Sales Market Share by Application (2017-2022)
Table 41. APAC Daratumumab Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Daratumumab Sales Market Share by Region (2017-2022)
Table 43. APAC Daratumumab Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Daratumumab Revenue Market Share by Region (2017-2022)
Table 45. APAC Daratumumab Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Daratumumab Sales Market Share by Type (2017-2022)
Table 47. APAC Daratumumab Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Daratumumab Sales Market Share by Application (2017-2022)
Table 49. Europe Daratumumab Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Daratumumab Sales Market Share by Country (2017-2022)
Table 51. Europe Daratumumab Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Daratumumab Revenue Market Share by Country (2017-2022)
Table 53. Europe Daratumumab Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Daratumumab Sales Market Share by Type (2017-2022)
Table 55. Europe Daratumumab Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Daratumumab Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Daratumumab Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Daratumumab Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Daratumumab Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Daratumumab Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Daratumumab Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Daratumumab Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Daratumumab Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Daratumumab Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Daratumumab
Table 66. Key Market Challenges & Risks of Daratumumab
Table 67. Key Industry Trends of Daratumumab
Table 68. Daratumumab Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Daratumumab Distributors List
Table 71. Daratumumab Customer List
Table 72. Global Daratumumab Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Daratumumab Sales Market Forecast by Region
Table 74. Global Daratumumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Daratumumab Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Daratumumab Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Daratumumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Daratumumab Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Daratumumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Daratumumab Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Daratumumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Daratumumab Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Daratumumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Daratumumab Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Daratumumab Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Daratumumab Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Daratumumab Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Daratumumab Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Daratumumab Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Daratumumab Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Daratumumab Revenue Market Share Forecast by Application (2023-2028)
Table 92. Johnson＆Johnson Basic Information, Daratumumab Manufacturing Base, Sales Area and Its Competitors
Table 93. Johnson＆Johnson Daratumumab Product Offered
Table 94. Johnson＆Johnson Daratumumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Johnson＆Johnson Main Business
Table 96. Johnson＆Johnson Latest Developments
List of Figures
Figure 1. Picture of Daratumumab
Figure 2. Daratumumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Daratumumab Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Daratumumab Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Daratumumab Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 100mg Injection
Figure 10. Product Picture of 400mg Injection
Figure 11. Global Daratumumab Sales Market Share by Type in 2021
Figure 12. Global Daratumumab Revenue Market Share by Type (2017-2022)
Figure 13. Daratumumab Consumed in Multiple Myeloma
Figure 14. Global Daratumumab Market: Multiple Myeloma (2017-2022) & (K Pcs)
Figure 15. Daratumumab Consumed in Diffuse Large B Cell Lymphoma
Figure 16. Global Daratumumab Market: Diffuse Large B Cell Lymphoma (2017-2022) & (K Pcs)
Figure 17. Daratumumab Consumed in Follicular Lymphoma
Figure 18. Global Daratumumab Market: Follicular Lymphoma (2017-2022) & (K Pcs)
Figure 19. Daratumumab Consumed in Mantle Cell Lymphoma
Figure 20. Global Daratumumab Market: Mantle Cell Lymphoma (2017-2022) & (K Pcs)
Figure 21. Daratumumab Consumed in Other
Figure 22. Global Daratumumab Market: Other (2017-2022) & (K Pcs)
Figure 23. Global Daratumumab Sales Market Share by Application (2017-2022)
Figure 24. Global Daratumumab Revenue Market Share by Application in 2021
Figure 25. Daratumumab Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Daratumumab Revenue Market Share by Company in 2021
Figure 27. Global Daratumumab Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Daratumumab Revenue Market Share by Geographic Region in 2021
Figure 29. Global Daratumumab Sales Market Share by Region (2017-2022)
Figure 30. Global Daratumumab Revenue Market Share by Country/Region in 2021
Figure 31. Americas Daratumumab Sales 2017-2022 (K Pcs)
Figure 32. Americas Daratumumab Revenue 2017-2022 ($ Millions)
Figure 33. APAC Daratumumab Sales 2017-2022 (K Pcs)
Figure 34. APAC Daratumumab Revenue 2017-2022 ($ Millions)
Figure 35. Europe Daratumumab Sales 2017-2022 (K Pcs)
Figure 36. Europe Daratumumab Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Daratumumab Sales 2017-2022 (K Pcs)
Figure 38. Middle East & Africa Daratumumab Revenue 2017-2022 ($ Millions)
Figure 39. Americas Daratumumab Sales Market Share by Country in 2021
Figure 40. Americas Daratumumab Revenue Market Share by Country in 2021
Figure 41. United States Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Daratumumab Sales Market Share by Region in 2021
Figure 46. APAC Daratumumab Revenue Market Share by Regions in 2021
Figure 47. China Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Daratumumab Sales Market Share by Country in 2021
Figure 54. Europe Daratumumab Revenue Market Share by Country in 2021
Figure 55. Germany Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Daratumumab Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Daratumumab Revenue Market Share by Country in 2021
Figure 62. Egypt Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Daratumumab Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Daratumumab in 2021
Figure 68. Manufacturing Process Analysis of Daratumumab
Figure 69. Industry Chain Structure of Daratumumab
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
